Fats - Cardio Metabolic Risks

The economic burden of lipid disorders is substantial because of the impact of lipid levels on the risk of cardiovascular disease and coronary heart disease events. The direct and indirect costs of all types of cardiovascular disease in 2015 were estimated to be $706.2 billion. The cost of cardiovascular disease exceeds that of any other high-cost medical conditions. For example, in 2008, the estimated total cost of all cancers was $228 billion and in 2007, the cost attributable to diabetes mellitus was $174 billion.

The monetary load of lipid condition is considerable due to the impact of lipid altitudes on the risk of cardiovascular disease and coronary heart disease trials. The nature of fat is for the most part indicated by the relative substance of SFA, monounsaturated (MUFA), and polyunsaturated unsaturated fats (PUFA) including the extent or measure of vital unsaturated fats, that is, linoleic corrosive (LA) and α-linolenic corrosive (ALA), as well as the extent or measure of long-chain n-3 unsaturated fats (n-3 LCPUFA), that is, eicosapentaenoic corrosive (EPA) and docosahexaenoic corrosive (DHA). Coronary illness is perceived to be the reason for death for 80% of individuals with diabetes

  • Coronary Heart Disease
  • Dietary fat
  • Cardiovascular disease (CVD)
  • Insulin resistance
  • Thrombosis
  • Atherosclerosis
  • Arrhythmias
  • Hypertension
  • Heart failure

Related Conference of Fats - Cardio Metabolic Risks

December 01-02, 2021

18th International Conference on Metabolomics and Proteomics

Frankfurt, Germany
December 07-07, 2021

5th International Conference on Protein Engineering

London, UK
December 08-09, 2021

World Congress on Biosensors and Bioelectronics

Barcelona, Spain
December 08-08, 2021

2nd International Conference on Nucleic Acids

London, UK
December 10-10, 2021

27th Asia Pacific Biotechnology Congress

London, UK
December 16-16, 2021

25th World Congress on Pharmaceutical Biotechnology

Barcelona, Spain
December 27-27, 2021

12th Tissue Repair and Regeneration Congress

Amsterdam, Netherlands
December 30-30, 2021

3rd International Conference on Biomarkers and Cell Biology

Amsterdam, Netherlands
December 30-30, 2021

Glycobiology Biochem Conference 2021

London, UK
February 25-26, 2022

International Conference on Biotechnology

Singapore City,Singapore
April 20-21, 2022

International Bio Summit and Expo

London, UK
May 02-03, 2022

12th World Glycobiology Congress

Zurich, Switzerland
July 11-12, 2022


Vienna, Austria
July 11-12, 2022

"18th World Congress on Structural Biology"

Paris, France
August 22-23, 2022

15th International Conference on Proteomics, Genomics & Bioinformatics

Singapore City, Singapore
September 12-13, 2022

"23rd Global Summit on Analytical and Bioanlaytical Techniques"

Prague, Czech Republic
September 26-27, 2022

26th European Biotechnology Congress

Paris, France

Fats - Cardio Metabolic Risks Conference Speakers

Recommended Sessions

Related Journals

Are you interested in